Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-16 4:30 pm Purchase |
2023-10-12 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
2,893,615 9.990% |
1,326,368 (+84.63%) |
Filing History |
| 2023-10-03 4:05 pm Purchase |
2023-09-28 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,567,247 9.990% |
339,930 (+27.70%) |
Filing History |
| 2023-09-22 4:22 pm Purchase |
2023-07-28 | 13G | Complete Solaria, Inc. CSLR |
Carlyle Group Inc. CG |
2,745,879 5.700% |
2,745,879 (New Position) |
Filing History |
| 2023-09-14 4:05 pm Purchase |
2023-09-12 | 13D | Carlyle Credit Income Fund CCIF |
Carlyle Group Inc. CG |
4,785,628 41.000% |
1,269,537 (+36.11%) |
Filing History |
| 2023-08-30 5:19 pm Purchase |
2023-08-28 | 13D | Carlyle Credit Income Fund CCIF |
Carlyle Group Inc. CG |
3,516,091 33.800% |
2,672,060 (+316.58%) |
Filing History |
| 2023-08-18 4:16 pm Unchanged |
2023-08-08 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
Carlyle Group Inc. CG |
193,196 7.800% |
0 (Unchanged) |
Filing History |
| 2023-08-18 4:15 pm Purchase |
2023-08-08 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,227,317 12.300% |
1,227,317 (New Position) |
Filing History |
| 2023-08-02 5:01 pm Sale |
2023-07-18 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
1,872,764 4.200% |
-544,073 (-22.51%) |
Filing History |
| 2023-07-17 4:40 pm Sale |
2023-07-14 | 13D | Carlyle Credit Income Fund CCIF |
Carlyle Group Inc. CG |
844,031 8.100% |
-2,874,225 (-77.30%) |
Filing History |
| 2023-07-05 4:17 pm Sale |
2023-06-28 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,416,837 5.500% |
-543,394 (-18.36%) |
Filing History |
| 2023-05-10 4:32 pm Unchanged |
2023-05-08 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-05-09 4:31 pm Purchase |
2023-05-02 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Carlyle Group Inc. CG |
273,046 8.200% |
64,250 (+30.77%) |
Filing History |
| 2023-04-13 4:06 pm Sale |
2023-03-28 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,960,231 6.700% |
-9,925 (-0.33%) |
Filing History |
| 2023-04-13 4:05 pm Purchase |
2023-03-27 | 13D | Exicure, Inc. XCUR |
Carlyle Group Inc. CG |
57,427 3.400% |
341 (+0.60%) |
Filing History |
| 2023-03-09 4:17 pm Purchase |
2023-03-01 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Carlyle Group Inc. CG |
2,935,106 6.700% |
2,935,106 (New Position) |
Filing History |
| 2023-02-23 4:15 pm Purchase |
2023-02-16 | 13D | Spruce Biosciences, Inc. SPRB |
Carlyle Group Inc. CG |
3,734,518 9.200% |
1,932,000 (+107.18%) |
Filing History |
| 2023-02-13 2:49 pm Sale |
2023-02-14 | 13G | The Carlyle Group Inc. CG |
Capital World Investors | 2,217,000 0.600% |
-17,098,259 (-88.52%) |
Filing History |
| 2023-02-10 4:16 pm Purchase |
2022-12-31 | 13G | HilleVax, Inc. HLVX |
Carlyle Group Inc. CG |
1,838,486 5.500% |
1,838,486 (New Position) |
Filing History |
| 2023-02-10 4:16 pm Sale |
2022-12-31 | 13G | ZoomInfo Technologies Inc. ZI |
Carlyle Group Inc. CG |
36,662,469 9.100% |
-7,579,513 (-17.13%) |
Filing History |
| 2023-02-10 4:14 pm Purchase |
2022-12-31 | 13G | Vaxcyte, Inc. PCVX |
Carlyle Group Inc. CG |
2,070,724 2.600% |
2,070,724 (New Position) |
Filing History |